Literature DB >> 18509648

Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.

Michela G Schäppi1, Vincent Jaquet, Dominique C Belli, Karl-Heinz Krause.   

Abstract

Chronic granulomatous disease (CGD) is an immunodeficiency caused by the lack of the superoxide-producing phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. However, CGD patients not only suffer from recurrent infections, but also present with inflammatory, non-infectious conditions. Among the latter, granulomas figure prominently, which gave the name to the disease, and colitis, which is frequent and leads to a substantial morbidity. In this paper, we systematically review the inflammatory lesions in different organs of CGD patients and compare them to observations in CGD mouse models. In addition to the more classical inflammatory lesions, CGD patients and their relatives have increased frequency of autoimmune diseases, and CGD mice are arthritis-prone. Possible mechanisms involved in CGD hyperinflammation include decreased degradation of phagocytosed material, redox-dependent termination of proinflammatory mediators and/or signaling, as well as redox-dependent cross-talk between phagocytes and lymphocytes (e.g. defective tryptophan catabolism). As a conclusion from this review, we propose the existence of ROS high and ROS low inflammatory responses, which are triggered as a function of the level of reactive oxygen species and have specific characteristics in terms of physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509648     DOI: 10.1007/s00281-008-0119-2

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  178 in total

1.  Rac2 is critical for neutrophil primary granule exocytosis.

Authors:  Dalia Abdel-Latif; Melissa Steward; Dawn L Macdonald; Gordon A Francis; Mary C Dinauer; Paige Lacy
Journal:  Blood       Date:  2004-04-08       Impact factor: 22.113

2.  Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease.

Authors:  G R Yeaman; K Froebel; G Galea; A Ormerod; S J Urbaniak
Journal:  Br J Dermatol       Date:  1992-01       Impact factor: 9.302

3.  Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A.

Authors:  Elaine Hatanaka; Beatriz Tavares Costa Carvalho; Antônio Condino-Neto; Ana Campa
Journal:  Immunol Lett       Date:  2004-06-15       Impact factor: 3.685

4.  Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species.

Authors:  Kyra A Gelderman; Malin Hultqvist; Angela Pizzolla; Ming Zhao; Kutty Selva Nandakumar; Ragnar Mattsson; Rikard Holmdahl
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

5.  Chorioretinal lesions in chronic granulomatous disease of childhood. Clinicopathologic correlations.

Authors:  H E Grossniklaus; K E Frank; G Jacobs
Journal:  Retina       Date:  1988       Impact factor: 4.256

6.  Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease.

Authors:  R N Danziger; A T Goren; J Becker; J M Greene; S D Douglas
Journal:  J Pediatr       Date:  1993-02       Impact factor: 4.406

7.  Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease.

Authors:  Jean-Benoit Arlet; Achile Aouba; Felipe Suarez; Stephane Blanche; Dominique Valeyre; Alain Fischer; Diane Damotte; Christophe Cellier; Olivier Hermine
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-02       Impact factor: 2.566

8.  Progressive esophageal dysfunction in chronic granulomatous disease.

Authors:  J F Markowitz; E Aronow; A R Rausen; H Aiges; M Silverberg; F Daum
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

Review 9.  Resolution of inflammation: state of the art, definitions and terms.

Authors:  Charles N Serhan; Sue D Brain; Christopher D Buckley; Derek W Gilroy; Christopher Haslett; Luke A J O'Neill; Mauro Perretti; Adriano G Rossi; John L Wallace
Journal:  FASEB J       Date:  2007-02       Impact factor: 5.191

10.  Neutrophils from p40phox-/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing.

Authors:  Chris D Ellson; Keith Davidson; G John Ferguson; Rod O'Connor; Len R Stephens; Phillip T Hawkins
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

View more
  56 in total

1.  Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.

Authors:  Colleen J Lewis; Brian A Cobb
Journal:  Eur J Immunol       Date:  2011-08-04       Impact factor: 5.532

Review 2.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

3.  Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.

Authors:  Yuka Okura; Masafumi Yamada; Futoshi Kuribayashi; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-02-10       Impact factor: 8.317

Review 4.  Gene therapy of chronic granulomatous disease: the engraftment dilemma.

Authors:  Manuel Grez; Janine Reichenbach; Joachim Schwäble; Reinhard Seger; Mary C Dinauer; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

Review 5.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

Review 6.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

7.  Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase.

Authors:  Chaim O Jacob; Miriam Eisenstein; Mary C Dinauer; Wenyu Ming; Qiang Liu; Sutha John; Francesco P Quismorio; Andreas Reiff; Barry L Myones; Kenneth M Kaufman; Deborah McCurdy; John B Harley; Earl Silverman; Robert P Kimberly; Timothy J Vyse; Patrick M Gaffney; Kathy L Moser; Marisa Klein-Gitelman; Linda Wagner-Weiner; Carl D Langefeld; Don L Armstrong; Raphael Zidovetzki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

8.  Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease.

Authors:  Aristóteles Álvarez-Cardona; Ana Luisa Rodríguez-Lozano; Lizbeth Blancas-Galicia; Francisco Eduardo Rivas-Larrauri; Marco A Yamazaki-Nakashimada
Journal:  J Clin Immunol       Date:  2011-11-26       Impact factor: 8.317

9.  An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD.

Authors:  Melody Yue Zeng; Duy Pham; Juhi Bagaitkar; Jianyun Liu; Karel Otero; Ming Shan; Thomas A Wynn; Frank Brombacher; Randy R Brutkiewicz; Mark H Kaplan; Mary C Dinauer
Journal:  Blood       Date:  2013-02-20       Impact factor: 22.113

Review 10.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.